Key result
Clotting time measured by a point-of-care Russell's viper venom test was prolonged proportionally to the anti-Xa activity of apixaban during the perioperative period.
Why the study?
Conventional coagulation tests, such as prothrombin time and activated partial thromboplastin time, are not sensitive to anticoagulation by apixaban.
Does the RVV test accurately estimate the anti-Xa level induced by apixaban during the perioperative period in a patient undergoing spine surgery?
Case Report (n=1)
No
Does the RVV test accurately estimate the anti-Xa level induced by apixaban during the perioperative period in a patient undergoing spine surgery?
The RVV test using ClotPro may be a useful point-of-care assay for estimating the residual anti-Xa effect of apixaban during the perioperative period.
Answers are grounded in this paper and cite their sources.
May support point-of-care RVV testing for perioperative apixaban monitoring; leaves open validation in larger studies.
BACKGROUND: Conventional coagulation tests, such as prothrombin time and activated partial thromboplastin time, are not sensitive to anticoagulation by apixaban. We evaluated the antithrombotic effect of apixaban using a Russell viper venom (RVV) test for a patient who underwent posterior spine fusion surgery. CASE PRESENTATION: An 84-year-old man was scheduled for percutaneous posterior spine fusion. He continued apixaban until the night before surgery and resumed it on the first day after surgery. We performed an RVV test as point-of-care coagulation monitoring in combination with chromogenic anti-activated factor X (anti-Xa) activity, prothrombin time, and activated partial thromboplastin time. Clotting time with the RVV test was prolonged according to the anti-Xa activity of apixaban, which was in the therapeutic range during surgery. CONCLUSIONS: An RVV test might be useful as a point-of-care assay for estimation of the anti-Xa level induced by apixaban during the perioperative period.
No takes yet. Share an insight, caveat, or question.
Suzuki et al. (2021) conducted a case report in Atrial fibrillation and lumbar compression fracture (n=1). Russell's viper venom (RVV) test was evaluated on Clotting time (CT) with RVV test. Clotting time measured by a point-of-care Russell's viper venom test was prolonged proportionally to the anti-Xa activity of apixaban during the perioperative period.
Synapse has enriched 10 related papers. Consider them for comparative context: